HCPLive Network

Altering Hormone Levels in Fetal Brain Affects Risk of Obesity

According to the report, altering the hormonal levels of insulin and leptin in the brains of developing fetuses has the potential to modify cellular development in the appetite sector of the brain; these results offer insight to the source of obesity.

The study was performed by researchers from the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed). The researchers utilized fetal neural stem cells from animal models and discovered that levels of leptin or insulin that had been altered had noticeable effects on the brain development of the offspring.

This recent study embellishes upon a previous study performed by LA BioMed, published in Brain Research in March; the findings of that study showed evidence that infants born to nutritionally deprived mothers are “programmed” to consume more food due to the lack of neurons in the region of the brain that controls appetite, indicating that overeating is programmed before birth.

During the course of the study, the researchers discovered that by modifying the levels of leptin in the animal models, neural stem cells developed more neurons; they also discovered that modifying the levels of insulin in the brain enhanced the creation of more astrocytes.

Both actions, however, could only take place at the expense of the development of other brain cells.

Leptin is known to play a role in the brain as a continuous appetite regulator, while insulin serves as an interim appetite regulator.

Significantly, the levels of leptin and insulin are altered in the infants of mothers who suffer from gestational diabetes, inadequate nutrition, or obesity during pregnancy.

"This study shows these two hormones influence the makeup of brain cells and how many cells we develop," stated a principal researcher and corresponding author of the study Mina Desai, PhD. "Our cellular makeup is akin to the foundation for a house. If the foundation isn't constructed properly, you can try and fix it but you will still have a problem. The same is true for people with fewer cells to regulate appetite and maintain stable and proper function of brain."

In this latest study, the researchers found less separation and differentiation of the neural stem cells present in the brains of a newborn with low birth weight in comparison to normal birth weight within the animal models.

These findings correlate with the results of previous studies, which have shown that a small birth weight which is followed by escalated growth is linked to a higher risk of adult obesity, type 2 diabetes, hypertension, osteoporosis, and cardiovascular disease.

Over 60% of American adults are overweight, and 20% are obese; roughly 17% of children and adolescents aged from two to nineteen years old are considered obese in America. This poses as a serious health risk, as type 2 diabetes is present in 11% of children and adolescents.

“By studying the ways in which leptin and insulin communicate with neural stem cells to divide and direct the cell fate, we may one day be able to come up with a new way to combat obesity," said Desai. "We have few effective methods for preventing or treating obesity, even though it is a leading cause of death in our society."

This study is published online in Endocrinology.

Further Reading
App will help patients with diabetes log their hypoglycemic events and achieve better control of these events by becoming more aware of preceding signs and symptoms.
Provocative research raises the question of whether we should we look at Alzheimer’s disease as “type 3 diabetes.”
Presentation at CMHC 2014 provides updates on emerging classes of diabetes treatment, including preliminary data from current clinical trials.
For stroke survivors, annual direct costs are comparable at 10 years and between 3 to 5 years for ischemic stroke but are higher at 10 years after hemorrhagic stroke, according to a study published online Oct. 23 in Stroke.
Cardiovascular disease is a long-term complication of type 1 diabetes mellitus, and more attention toward management of its associated risk factors and modifiers is urged in a scientific statement published in the October issue of Diabetes Care.
Adolescent depression is a serious mental illness that results in negative health consequences and frequently recurs later in life. Although the prevalence rate of depression is around 20 percent among African American and European-American adolescents, the associated risks and utilization rates vary greatly.
Recent pharmaceutical studies show work in helping patients with high blood pressure and elevated cholesterol levels.
More Reading